The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC)
Open accessAbstract
Hepatocellular carcinoma (HCC) is the most common histological form of primary liver cancer; the tumor cells having retained features of hepatocytic differentiation. It is important to emphasize the heterogeneity of the histological background on which the tumor develops. Most HCCs complicate the evolution of an active or inactive cirrhosis. However, some tumors occur on livers with minimal histological changes; the prevalence of such cases varies from one geographical region to the other; being much higher in the southern half of Africa (around 40% of HCCs) than in Asia, America and Europe, where at least 90% of HCCs are associated in the cirrhosis. This heterogeneity is probably a reflection of different environmental and genetic factors. A large number of epidemiological and molecular studies have indeed clearly demonstrated the prime importance of environmental factors to the development of primary liver cancers in humans. Chronic hepatitis B (HBV) and C (HCV) infections are major risk factors. This review will mainly analyse the impact of chronic HBV infection but it is important to emphasize the potential synergistic effects between HBV and HCV, as well as between viral infections and other environmental factors, such as alcohol, chemical carcinogens (see review by Dr Wogan) and other, still poorly defined, hormonal factors which may account for the higher incidence of the tumor in man. Finally the review by Dr Buendia highlights the emerging issue of liver-cancer genetics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828
Viral Hepatitis and Liver Disease
Vyas, G. N., Dienstag, J. L., & Hoofnagle, J. H. (1985) · Medical Entomology and Zoology · Cited by 1,860
de Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
de Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L., & Dejean, A. (1991) · Cell · doi:10.1016/0092-8674(91)90113-d · Cited by 1,343
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., & Chisari, F. V. (1999) · Science · doi:10.1126/science.284.5415.825 · Cited by 1,223
Tiollais, P., Pourcel, C., & Dejean, A. (1985) · Nature · doi:10.1038/317489a0 · Cited by 1,205
HBx gene of hepatitis B virus induces liver cancer in transgenic mice
Kim, C.-M., Koike, K., Saito, I., Miyamura, T., & Jay, G. (1991) · Nature · doi:10.1038/351317a0 · Cited by 1,158
THE MOLECULAR BIOLOGY OF THE HEPATITIS B VIRUSES
Ganem, D., & Varmus, H. E. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003251 · Cited by 1,084
Houghton, M., Weiner, A., Han, J., Kuo, G., & Choo, Q.-L. (1991) · Hepatology · doi:10.1002/hep.1840140227 · Cited by 863
Rehermann, B., Ferrari, C., Pasquinelli, C., & Chisari, F. V. (1996) · Nature Medicine · doi:10.1038/nm1096-1104 · Cited by 854
Greenberg, H. B. (1970) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1970.03170210085033 · Cited by 848
Shafritz, D. A., Shouval, D., Sherman, H. I., Hadziyannis, S. J., & Kew, M. C. (1981) · New England Journal of Medicine · doi:10.1056/nejm198110293051807 · Cited by 711
Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma
Wang, J., Chenivesse, X., Henglein, B., & Bréchot, C. (1990) · Nature · doi:10.1038/343555a0 · Cited by 671
Self-citationOccult Hepatitis B Virus Infection in Patients with Chronic Hepatitis C Liver Disease
Cacciola, I., Pollicino, T., Squadrito, G., Cerenzia, G., Orlando, M. E., & Raimondo, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907013410104 · Cited by 666
Donato, F., Boffetta, P., & Puoti, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980130)75:3<347::aid-ijc4>3.0.co;2-2 · Cited by 543
(1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-6-835_1 · Cited by 532
Bréchot, C., Degos, F., Lugassy, C., Thiers, V., Zafrani, S., Franco, D., Bismuth, H., Trépo, C., Benhamou, J.-P., Wands, J., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501313120503 · Cited by 459
Self-citationHBV X Protein Alters the DNA Binding Specificity of CREB and ATF-2 by Protein-Protein Interactions
Maguire, H. F., Hoeffler, J. P., & Siddiqui, A. (1991) · Science · doi:10.1126/science.1827531 · Cited by 454
Woodchuck hepatitis virus X protein is required for viral infection in vivo
Zoulim, F., Saputelli, J., & Seeger, C. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.2026-2030.1994 · Cited by 453
(1992) · Springer eBooks · doi:10.1007/978-4-431-68177-9 · Cited by 434
Dejean, A., Bougueleret, L., Grzeschik, K.-H., & Tiollais, P. (1986) · Nature · doi:10.1038/322070a0 · Cited by 407
Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
Murakami, Y., Hayashi, K., Hirohashi, S., & Sekiya, T. (1991) · PubMed · Cited by 374
Self-citationImmune Pathogenesis of Hepatocellular Carcinoma
Nakamoto, Y., Guidotti, L. G., Kuhlen, C. V., Fowler, P., & Chisari, F. V. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.341 · Cited by 373
The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks
Chen, H. S., Kaneko, S., Girones, R., Anderson, R. W., Hornbuckle, W. E., Tennant, B. C., Cote, P. J., Gerin, J. L., Purcell, R. H., & Miller, R. H. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1218-1226.1993 · Cited by 370
Brechot, C., Scotto, J., Charnay, P., Hadchouel, M., Degos, F., Trepo, C., & Tiollais, P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90182-3 · Cited by 334
Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis
Elmore, L. W., Hancock, A. R., Chang, S.-F., Wang, X. W., Chang, S., Callahan, C. P., Geller, D. A., Will, H., & Harris, C. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14707 · Cited by 333
Hepatitis B virus persistence after recovery from acute viral hepatitis.
Michalak, T. I., Pasquinelli, C., Guilhot, S., & Chisari, F. V. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116950 · Cited by 330
TRANSMISSION OF HEPATITIS B FROM HEPATITIS-B-SERONEGATIVE SUBJECTS
Thiers, V, Kremsdorf, D., Schellekens, H., Goudeau, A., Sninsky, J., Nakajima, E., Mack, D., Driss, F., Wands, J., Tiollais, P., et al. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92891-7 · Cited by 314
Doria, M., Klein, N. P., Lucito, R., & Schneider, R. J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00156.x · Cited by 313
Hagen, T. M., Huang, S., Curnutte, J., Fowler, P., Martinez, V, Wehr, C. M., Ames, B. N., & Chisari, F. V. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12808 · Cited by 311
The oncogenic potential of herpes simplex viruses: evidence for a ‘hit-and-run’ mechanism
Galloway, D. A., & McDougall, J. K. (1983) · Nature · doi:10.1038/302021a0 · Cited by 310
Feitelson, M. A., Zhu, M., Duan, L., & London, W. T. (1993) · PubMed · Cited by 307
"Occult" hepatitis B virus as source of infection in liver transplant recipients
Chazouillères, O., Mamish, D., Kim, M., Carey, K., Wright, T. L., Ferrell, L., Roberts, J. P., & Ascher, N. L. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90934-2 · Cited by 303
Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor α
Su, F., & Schneider, R. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8744 · Cited by 300
HCV-associated liver cancer without cirrhosis
De Mitri, M. S., Pisi, E., Poussin, K., Paterlini, P., Bréchot, C., Baccarini, P., D'Errico, A., Grigiani, W., Alberti, A., Pontisso, P., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90400-x · Cited by 294
Self-citationHepatitis B virus HBx protein deregulates cell cycle checkpoint controls.
Benn, J., & Schneider, R. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11215 · Cited by 288
The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice
Terradillos, O., Billet, O., Renard, C.-A., Levy, R., Molina, T., Briand, P., & Buendia, M. A. (1997) · Oncogene · doi:10.1038/sj.onc.1200850 · Cited by 285
Geographic Variation of p53 Mutational Profile in Nonmalignant Human Liver
Aguilar, F., Harris, C. C., Sun, T., Hollstein, M., & Cerutti, P. (1994) · Science · doi:10.1126/science.8191284 · Cited by 282
Benn, J., Su, F., Doria, M., & Schneider, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.4978-4985.1996 · Cited by 281
Delayed early embryonic lethality following disruption of the murine cyclin A2 gene
Murphy, M., Stinnakre, M.-G., Senamaud-Beaufort, C., Winston, N. J., Sweeney, C., Kubelka, M., Carrington, M., Bréchot, C., & Sobczak-Thépot, J. (1997) · Nature Genetics · doi:10.1038/ng0197-83 · Cited by 279
Self-citationRelationship Between Hepatocellular Carcinoma and Cirrhosis
Kew, M., & Popper, H. (1984) · Seminars in Liver Disease · doi:10.1055/s-2008-1040653 · Cited by 260
Truant, R., Antunovic, J., Greenblatt, J., Prives, C., & Cromlish, J. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1851-1859.1995 · Cited by 255
Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours
Fourel, G., Trepo, C., Bougueleret, L., Henglein, B., Ponzetto, A., Tiollais, P., & Buendia, M.-A. (1990) · Nature · doi:10.1038/347294a0 · Cited by 249
Paterlini, P., Poussin, K., Kew, M., Franco, D., & Brechot, C. (1995) · Hepatology · doi:10.1002/hep.1840210208 · Cited by 249
Hepatitis B virus X protein interacts with a probable cellular DNA repair protein
Lee, T. H., Elledge, S. J., & Butel, J. S. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.1107-1114.1995 · Cited by 248
Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein
Yu, D.-Y., Moon, H.-B., Son, J.-K., Jeong, S., Yu, S.-L., Yoon, H., Han, Y.-M., Lee, C.-S., Park, J.-S., Lee, C.-H., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80172-x · Cited by 242
Clinical and virological profiles in patients with multiple hepatitis virus infections
Pontisso, P., Ruvoletto, M. G., Fattovich, G., Chemello, L., Gallorini, A., Ruol, A., & Alberti, A. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90161-5 · Cited by 237
Höhne, M., Schaefer, S., Seifer, M., Feitelson, M. A., Paul, D., & Gerlich, W. H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08220.x · Cited by 236
Leukaemia disease genes: large-scale cloning and pathway predictions
Li, J., Shen, H., Himmel, K. L., Dupuy, A. J., Largaespada, D. A., Nakamura, T., Shaughnessy, J. D., Jenkins, N. A., & Copeland, N. G. (1999) · Nature Genetics · doi:10.1038/15531 · Cited by 235
HBx Protein of Hepatitis B Virus Activates Jak1-STAT Signaling
Lee, Y.-H., & Yun, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25510 · Cited by 234
Hepatitis B Virus X Protein Is both a Substrate and a Potential Inhibitor of the Proteasome Complex
Hu, Z., Zhang, Z., Doo, E., Coux, O., Goldberg, A. L., & Liang, T. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7231-7240.1999 · Cited by 232
Parés, A., Barrera, J. M., Caballería, J., Ercilla, G., Bruguera, M., Caballería, L., Castillo, R., & Rodés, J. (1990) · Hepatology · doi:10.1002/hep.1840120608 · Cited by 230
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07236-5 · Cited by 230
Benvegnù, L. (1998) · Padua Research Archive (University of Padova) · Cited by 221
Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas
Su, Q., Schröder, C. H., Hofmann, W. J., Otto, G., Pichlmayr, R., & Bannasch, P. (1998) · Hepatology · doi:10.1002/hep.510270428 · Cited by 219
Liver/Kidney Microsome Antibody Type 1 and Hepatitis C Virus Infection
Lunel, F., Abuaf, N., Frangeul, L., Grippon, P., Perrin, M., Coz, Y. L., Valla, D., Borotto, E., Yamamoto, A.-M., Huraux, J.-M., et al. (1992) · Hepatology · doi:10.1002/hep.1840160304 · Cited by 219
Koziel, M. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007107 · Cited by 216
Hepatitis B virus X‐gene product: A promiscuous transcriptional activator
Rossner, M. T. (1992) · Journal of Medical Virology · doi:10.1002/jmv.1890360207 · Cited by 211
Sirma, H., Giannini, C., Poussin, K., Paterlini, P., Kremsdorf, D., & Bréchot, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202867 · Cited by 207
Self-citationCommon evolutionary origin of hepatitis B virus and retroviruses.
Miller, R. H., & Robinson, W. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2531 · Cited by 204
Mendenhall, C. L., Seeff, L., Diehl, A. M., Ghosn, S. J., French, S. W., Gartside, P. S., Rouster, S. D., Buskell-Bales, Z., Grossman, C. J., Roselle, G. A., et al. (1991) · Hepatology · doi:10.1002/hep.1840140402 · Cited by 196
X-gene Product of Hepatitis B Virus Induces Apoptosis in Liver Cells
Kim, H., Lee, H., & Yun, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.381 · Cited by 194
Hepatitis B virus transactivator protein X interacts with the TATA-binding protein.
Qadri, I., Maguire, H. F., & Siddiqui, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1003 · Cited by 185
Slagle, B. L., Lee, T.-H., Medina, D. J., Finegold, M. J., & Butel, J. S. (1996) · Molecular Carcinogenesis · Cited by 181
Takada, S., Shirakata, Y., Kaneniwa, N., & Koike, K. (1999) · Oncogene · doi:10.1038/sj.onc.1203188 · Cited by 178
Fukuda, R., Ishimura, N., Niigaki, M., Hamamoto, S., Satoh, S., Tanaka, S., Kushiyama, Y., Uchida, Y., Ihihara, S., Akagi, S., et al. (1999) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199907)58:3<201::aid-jmv3>3.0.co;2-2 · Cited by 173
Shirakata, Y., Kawada, M., Fujiki, Y., Sano, H., Oda, M., Yaginuma, K., Kobayashi, M., & Koike, K. (1989) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1989.tb01686.x · Cited by 170
Hepatitis B Virus X Protein: Structure, Function and Biology
Murakami, S. (1999) · Intervirology · doi:10.1159/000024969 · Cited by 164
Hepadnaviral X protein: Review of recent progress
Benedict Yen, T. S. (1996) · Journal of Biomedical Science · doi:10.1007/bf02253575 · Cited by 163
In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA
Soussan, P., Garreau, F., Zylberberg, H., Ferray, C., Brechot, C., & Kremsdorf, D. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8098 · Cited by 163
Genetic heterogeneity of hepatocellular carcinoma.
Unsal, H., Yakicier, C., Marçais, C., Kew, M., Volkmann, M., Zentgraf, H., Isselbacher, K. J., & Ozturk, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.822 · Cited by 161
Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation
Shih, C. M., Chen, C. M., Chen, S. Y., & Lee, Y. H. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.1160-1171.1995 · Cited by 160
Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.
Nishida, N., Fukuda, Y., Kokuryu, H., Toguchida, J., Yandell, D. W., Ikenega, M., Imura, H., & Ishizaki, K. (1993) · PubMed · Cited by 151
Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway
Chirillo, P., Falco, M., Puri, P., Artini, M., Balsano, C., Levrero, M., & Natoli, G. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.641-646.1996 · Cited by 147
Noncytopathic Clearance of Lymphocytic Choriomeningitis Virus from the Hepatocyte
Guidotti, L. G., Borrow, P., Brown, A., McClary, H., Koch, R. J., & Chisari, F. V. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.10.1555 · Cited by 147
Korba, B. E., Wells, F. V., Baldwin, B. H., Côté, P. J., Tennant, B. C., Pópper, H., & Gerin, J. L. (1989) · Hepatology · doi:10.1002/hep.1840090321 · Cited by 147
Viral genetic variation: hepatitis B virus as a clinical example
Carman, W. F., Thomas, H. C., & Domingo, E. (1993) · The Lancet · doi:10.1016/0140-6736(93)90146-8 · Cited by 139
Hepatitis b Viruses and Hepatocellular Carcinoma
Buendia, M. A. (1992) · Advances in cancer research · doi:10.1016/s0065-230x(08)60306-1 · Cited by 137
Weil, R., Sirma, H., Giannini, C., Kremsdorf, D., Chable-Bessia, C., Dargemont, C., Bréchot, C., & Israël, A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6345 · Cited by 136
Self-citationSlagle, B. L., Zhou, Y.-Z., & Butel, J. S. (1991) · PubMed · Cited by 130
Wang, J., Zindy, F., Chenivesse, X., Lamas, E., Henglein, B., & Bréchot, C. (1992) · PubMed · Cited by 127
Self-citationAssociation between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease
Nalpas, B., Driss, F., Pol, S., Hamelin, B., Housset, C., Bréchot, C., & Berthelot, P. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90912-u · Cited by 126
Self-citationHepatitis B x antigen in hepatitis B virus carrier patients with liver cancer.
Wang, W. L., London, W. T., & Feitelson, M. A. (1991) · PubMed · Cited by 125
Fujimoto, Y., Hampton, L. L., Wirth, P. J., Wang, N. J., Xie, J. P., & Thorgeirsson, S. S. (1994) · PubMed · Cited by 123
Yaginuma, K., Kobayashi, H., Kobayashi, M., Morishima, T., Matsuyama, K., & Koike, K. (1987) · Journal of Virology · doi:10.1128/jvi.61.6.1808-1813.1987 · Cited by 119
The hepatitis B virus X protein up-regulates tumor necrosis factor α gene expression in hepatocytes
Lara‐Pezzi, E., Majano, P. L., Gómez-Gonzalo, M., García‐Monzón, C., Moreno‐Otero, R., Levrero, M., & López‐Cabrera, M. (1998) · Hepatology · doi:10.1002/hep.510280416 · Cited by 119
Goodwin, E. C., Naeger, L. K., Breiding, D. E., Androphy, E. J., & DiMaio, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.3925-3934.1998 · Cited by 113
Clonal analysis of macronodules in cirrhosis
Paradis, V., Laurendeau, I., Vidaud, M., & Bédossa, P. (1998) · Hepatology · doi:10.1002/hep.510280409 · Cited by 109
Sirma, H., Weil, R., Rosmorduc, O., Urban, S., Israël, A., Kremsdorf, D., & Bréchot, C. (1998) · Oncogene · doi:10.1038/sj.onc.1201737 · Cited by 106
Self-citationExpression of mutated hepatitis B virus X genes in human hepatocellular carcinomas
Poussin, K., Dienes, H. P., Sirma, H., Urban, S., Beaugrand, M., Franco, D., Schirmacher, P., Chot, C. B., & Paterlini-Bréchot, P. (1999) · International Journal of Cancer · Cited by 99
Self-citationEvidence for long‐range oncogene activation by hepadnavirus insertion.
Fourel, G., Couturier, J., Wei, Y., Apiou, F., Tiollais, P., & Buendia, M. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06542.x · Cited by 98
Cytokine inhibition of the hepatitis B virus core promoter
Romero, R. J., & Lavine, J. E. (1996) · Hepatology · doi:10.1002/hep.510230103 · Cited by 85
Takada, S., Kaneniwa, N., Tsuchida, N., & Koike, K. (1997) · Oncogene · doi:10.1038/sj.onc.1201369 · Cited by 83
Tumour suppressive properties of the adenovirus 5 E1A oncogene.
Mymryk, J. S. (1996) · PubMed · Cited by 83
Shintani, Y., Yotsuyanagi, H., Moriya, K., Fujie, H., Tsutsumi, T., Kanegae, Y., Kimura, S., Saito, I., & Koike, K. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-12-3257 · Cited by 81
Hepatitis C viremia and anti-HCV antibodies in alcoholics
Nalpas, B., Thiers, V., Pol, S., Driss, F., Thépot, V., Berthelot, P., & Bréchot, C. (1992) · Journal of Hepatology · doi:10.1016/0168-8278(92)90187-t · Cited by 80
Self-citationBergametti, F., Prigent, S., Luber, B., Benoit, A., Tiollais, P., Sarasin, A. R., & Transy, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202643 · Cited by 80
Immediate effects of reversible HTLV-ITax function: T-cell activation and apoptosis
Chlichlia, K., Moldenhauer, G., Daniel, P. T., Gazzolo, L., Schirrmacher, V., & Khazaie, K. (1995) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf02559873 · Cited by 79
Minami, M., Poussin, K., Bréchot, C., et al. (1995) · Genomics · doi:10.1006/geno.1995.9004 · Cited by 73
Self-citationShiratori, Y., Shiina, S., Zhang, P. Y., Ohno, E., Okudaira, T., Payawal, D. A., Ono, S. K., Imamura, M., Kato, N., & Omata, M. (1997) · Cancer · Cited by 73
Urashima, T., Saigo, K., Kobayashi, S. S., Imaseki, H., Matsubara, H., Koide, Y., Asano, T., Kondō, Y., Koike, K., & Isono, K. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80241-3 · Cited by 71
Hepatitis B virus transgenic mouse model of chronic liver disease
Larkin, J. D., Clayton, M. M., Sun, B. S., Perchonock, C. E., Morgan, J. L., Siracusa, L. D., Michaels, F. H., & Feitelson, M. A. (1999) · Nature Medicine · doi:10.1038/11347 · Cited by 68
Hepatic Preneoplasia in Hepatitis B Virus Transgenic Mice
Toshkov, I., Chisari, F. V., & Bannasch, P. (1994) · Hepatology · doi:10.1002/hep.1840200510 · Cited by 68
Tarn, C., Bilodeau, M. L., Hullinger, R. L., & ANDRISANI, O. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2327 · Cited by 68
Lian, Z., Pan, J., Liu, J., Zhang, S., Zhu, M.-H., Arbuthnot, P. B., Kew, M. C., & Feitelson, M. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202470 · Cited by 67
Hatada, I., Tokino, T., Ochiya, T., & Matsubara, K. (1988) · PubMed · Cited by 66
Cyclin A expression in human hematological malignancies: a new marker of cell proliferation.
Paterlini-Bréchot, P., Suberville, A., Zindy, F., Melle, J., Sonnier, M., Marie, J., Dreyfus, F., & Bréchot, C. (1993) · PubMed · Cited by 64
Self-citationCyclin A: Function and expression during cell proliferation
Desdouets, C., Sobczak‐Thépot, J., Murphy, M., & Bréchot, C. (1995) · Springer eBooks · doi:10.1007/978-1-4615-1809-9_9 · Cited by 58
Self-citationDeletion Mutants of the Hepatitis B Virus X Gene in Human Hepatocellular Carcinoma
Hsia, C. C., Nakashima, Y., & Tabor, E. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7882 · Cited by 56
Sequence analysis of hepatitis B virus DNA in immunologically negative infection
Preisler‐Adams, S., Schlayer, H. ‐., Peters, T., Hettler, F., Gerok, W., & Rasenack, J. W. F. (1993) · Archives of Virology · doi:10.1007/bf01313777 · Cited by 55
Étiemble, J., Degott, C., Renard, C. A., et al. (1994) · PubMed · Cited by 52
Petersen, J., Dandri, M., Bürkle, A., Zhang, L., & Rogler, C. E. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5455-5463.1997 · Cited by 49
Berasain, C., Patil, D., Perara, E., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201893 · Cited by 49
Lauer, U. M., Weiβ, L., Lipp, M., Hofschneider, P. H., & Kekulé, A. S. (1994) · Hepatology · doi:10.1002/hep.1840190106 · Cited by 48
Garcia, M., de Thé, H., Tiollais, P., Samarut, J., & Dejean, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.89 · Cited by 48
Sánchez‐Prieto, R., de Álava, E., Palomino, T., Viniegra, J. G., Fernandez, V., Cebrian, S., LLeonart, M. E., Cabello, P., Martı́n, P., Roman, C. S., et al. (1999) · Nature Medicine · doi:10.1038/12516 · Cited by 39
Pineau, P., Marchio, A., Terris, B., Mattéi, M., Tu, Z., Tiollais, P., & Dejean, A. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.7280-7284.1996 · Cited by 31
Cyclin a expression in human hematological malignancies: A new marker of cell proliferation
Patricia, P., Anne‐Marie, F., Zindy, F., Melle, J., Marie, J., Dreyfus, F., & Bréchot, C. (1992) · Biology of the Cell · doi:10.1016/0248-4900(92)90377-d · Cited by 30
Self-citationCoursaget, P., Cann, P. L., Leboulleux, D., Diop, M.-T. ̈., Bao, O., & Coll, A. M. (1991) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1991.tb04384.x · Cited by 27
Hepatitis B Virus DNA in Dane Particles: Evidence for the Presence of Replicative Intermediates
Scotto, J. M., Hadchouel, M., Wain–Hobson, S., Sonigo, P., Couroucé, A. M., Tiollais, P., & Bréchot, C. (1985) · The Journal of Infectious Diseases · doi:10.1093/infdis/151.4.610 · Cited by 24
Self-citationGanne‐Carrié, N., Kremsdorf, D., Garreau, F., Thévenin, M., Petit, M.-A., Nalpas, B., & Bréchot, C. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80329-7 · Cited by 12
Self-citation
Cited by
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Sarin, S. K., Kumar, M., Lau, G. K., Abbas, Z., Chan, H. L. Y., Chen, C. J., Chen, D. S., Chen, H. L., Chen, P. J., Chien, R. N., et al. (2016) · Hepatology International · doi:10.1007/s12072-015-9675-4 · Cited by 2,550
Murakami, Y., Yasuda, T., Saigo, K., Urashima, T., Toyoda, H., Okanoue, T., & Shimotohno, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209283 · Cited by 1,147
Self-citationGenome-wide survey of recurrent HBV integration in hepatocellular carcinoma
Sung, W.-K., Zheng, H., Li, S., Chen, R., Liu, X., Li, Y., Lee, N. P., Lee, W. H., Ariyaratne, P. N., Tennakoon, C., et al. (2012) · Nature Genetics · doi:10.1038/ng.2295 · Cited by 991
Bréchot, C., Thiers, V., Kremsdorf, D., Nalpas, B., Pol, S., & Paterlini-Bréchot, P. (2001) · Hepatology · doi:10.1053/jhep.2001.25172 · Cited by 560
Self-citationMolecular viral oncology of hepatocellular carcinoma
Block, T. M., Mehta, A. S., Fimmel, C. J., & Jordan, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206557 · Cited by 495
Metadata
- Authors
- Bréchot, C., Gozuacik, D., Murakami, Y., & Paterlini-Bréchot, P.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2000-06
- Volume
- 10
- Issue
- 3
- Pages
- 211-231
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2077311317
- Cited by
- 276
- References
- 121
- FWCI
- 11.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.